臨床試驗

BAROSTIM NEO Hypertension Pivotal Trial

NCT：NCT01679132 · COMPLETED

NCT IDNCT01679132

狀態COMPLETED

開始日期2013-04-12

完成時間2025-07-23

SponsorCVRx, Inc. (INDUSTRY)

First posted2012-09-05

Last updated2026-09-11

簡要摘要

The purpose of this clinical investigation (NCT01679132) is to assess the long-term safety and efficacy of the BAROSTIM NEO System in subjects currently participating in the BAROSTIM Hypertension Pivotal Trial (G120137).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。